Market Reports

Antibacterial drugs report shows B-lactam in demand 

27 September 2021

A report by Fact.MR reveals that the global antibacterial drugs market is projected to grow at a modest CAGR of 2.6% during the forecast period (2021-2031), expected to reach a value of US$62 billion. In the short run, the market is poised to expand at a CAGR of 1.5% from 2020-2025 to reach US$50 billion.  […]

Lithuania eyes major window of opportunity in life sciences 

13 September 2021

Enterprise Lithuania and the Lithuanian Biotechnology Association has announced that in 2020, the Lithuanian biotechnology sector grew by a record 87% and accounted for 2.5% of the Baltic nation’s GDP. Industry leaders gathering at the upcoming Life Sciences Baltics forum are now calling for more international collaborations, increased investment and ongoing government support to continue […]

Report predicts trends and forecasts for CRISPR 

10 September 2021

The “CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts 2021-2030” report has been added to ResearchAndMarkets.com’s offering.  The report features a study of the current market landscape and future opportunity for the players involved in the development of CRISPR based therapeutics for the treatment […]

Infographic: Biotech hot spots in a fragmented European landscape 

26 August 2021

McKinsey has mapped out 1,382 biotechs based in Europe and some interesting themes emerged, showing how European biotechs have established a position of strength from which to enter the industry’s next act. Over the past three years, Europe’s biotech industry has made meaningful progress on attracting capital and bringing products to market.  Europe’s complex biotech landscape comprises hundreds of companies, […]

Gene therapies could revolutionise CVDs, data says 

25 August 2021

Gene therapies could revolutionise the management of chronic cardiovascular diseases (CVDs) such as heart failure, according to GlobalData. The data and analytics company notes that there are currently 87* CVD gene therapies currently in development, and they hold potential to vastly improve patients’ quality of life.  Fiona Chisholm, Pharma Analyst at GlobalData said: “As the leading cause of death […]

The Operationalisation of Precision Medicine report

30 July 2021

Public Policy Projects (PPP) has launched a new report called ‘The Operationalisation of Precision Medicine.’ The report, which is now available to download, has been created in partnership with AstraZeneca. Precision medicine is a development in medical history that has the potential to ensure better outcomes for patients. The UK is ahead of many countries […]

Europe’s emerging biotechs: Challenges, opportunities and funding

30 July 2021

Listen to this article on the DDW Podcast: John Macdonald is Vice President, Venture & Financial Alliances at ICON. He examines the European biotech sector – its expertise and opportunities and potential for growth. By harnessing biological processes on a cellular and biomolecular level, biotech is benefitting industries as varied as agriculture and chemical production. Perhaps […]

Innovation and opportunity within Europe’s biotech sector

28 July 2021

Listen to this article on the DDW Podcast: Lu Rahman introduces a slice of European biotech expertise Thanks to the Covid-19 pandemic, the global biotech sector has been thrown into the spotlight, not just in the drug discovery and development word, but as a sector that the general public has come to know more closely, and […]

AI and big data will continue to disrupt pharmaceutical sector, says research

22 July 2021

The Covid-19 pandemic has given businesses opportunity to implement technology-fuelled changes to the way they operate. AI and big data/analytics have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes, as well as marketing and sales, according to a survey by GlobalData, a data and […]

Report reveals the potential of microbiome-targeting therapeutics

20 July 2021

GlobalData’s report, ‘Thematic Research: Microbiome-Targeted Therapeutics in Immunology’, reveals that 23 microbiome-targeting therapeutics are currently being developed in the US and the 5EU (France, Germany, Italy, Spain, UK) for gastrointestinal (GI), dermatological, and respiratory conditions. Each of these therapies aims to address these diseases by manipulating the microbiome. Microbiome is a space with high potential, […]

« Previous
Next »

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free